Ocata Therapeutics Inc fka OCAT

[rocky301]

The following "summary' is what you can expect to see when Orphan status is approved by EU commission and gives an example of time frames..

Public summary of opinion on orphan designation
Lentiviral vector containing the human ABCA4 gene for the treatment of Stargardt’s disease

the COMP adopted a positive opinion on 3 December 2009 recommending the granting of this designation.

On 2 February 2010, orphan designation (EU/3/09/720) was granted by the European Commission to Oxford BioMedica (UK) Ltd, United Kingdom, for lentiviral vector containing the human ABCA4 gene for the treatment of Stargardt’s disease.
http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2010/03/WC500075159.pdf

Decent site if you haven't see it.
Last 10 years
Status of orphan-designation applications
• A total of 1113 applications have been submitted to date for the designation of orphan medicines.
• A total of 760 positive opinions on orphan designation have been adopted by the COMP.
• A total of 269 applications have been withdrawn and 16 received a negative COMP opinion
• A total of 724 medicines have been granted orphan status by the European Commission.
http://www.ema.europa.eu/docs/en_GB/document_library/Report/2010/05/WC500090812.pdf